Performant Healthcare Inc Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Loss on disposal of assets and other
Impairment of long-lived assets
Impairment of goodwill
Loss on disposal of assets and impairment of long-lived assets
Loss on disposal of assets
Depreciation and amortization
Gain on lease modification
Right-of-use assets amortization
Stock-based compensation
Interest expense from debt issuance costs
Earnout mark-to-market
Amortization of debt issuance costs
Loss on debt extinguishment
Gain on sale of certain recovery contracts
Gain on sale of land and buildings
Changes in operating assets and liabilities:
Trade accounts receivable
Contract assets
Prepaid expenses and other current assets
Income tax receivable
Other assets
Accrued salaries and benefits
Accounts payable
Contract liabilities and other current liabilities
Estimated liability for appeals and disputes
Lease liabilities
Other liabilities

Net cash provided by operating activities
Cash flows from investing activities:
Purchase of property, equipment, and software
Proceeds from sale of certain recovery contracts
Proceeds from sales of property, equipment, and leasehold improvements
Net cash used in investing activities
Cash flows from financing activities:
Repayment of long-term loan payable
Debt issuance costs paid
Taxes paid related to net share settlement of stock awards
Proceeds from exercise of warrants
Proceeds from exercise of stock options
Borrowings from notes payable
Proceeds from public offering, net of costs
Borrowings from revolving loan
Net cash provided by (used in) financing activities
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of year
Cash, cash equivalents and restricted cash at end of year
Recognition of earnout shares issued
Recognition of warrants issued in debt financing
Non-cash investing activities:
Deferred asset acquisition payments
Supplemental disclosures of cash flow information:
Cash (received) paid for income taxes
Cash paid for interest
Reconciliation of the consolidated statements of cash flows to the consolidated balance sheets:
Cash and cash equivalents
Restricted cash

Comments